Recent machine-extracted executive movements from SEC 8-K Item 5.02 filings, source-linked. Every card cites the SEC source.
Showing 5151–5200 of 75391
On January 2, 2025, Ministry Partners Investment Company, LLC (the “Company”) announced that Brian S. Barbre, Senior Vice-President and Chief Financial Officer, has tendered his resignation and accepted a new employment opportunity.
On January 3, 2025, William Rieflin resigned from the Board of Directors (the “Board”) of RAPT Therapeutics, Inc. (the “Company”), effective immediately.
Jack A. Hockema, Executive Chair of the board of directors (the “Board”) of Kaiser Aluminum Corporation (the “Company”) and Chair of the Executive Committee of the Board, notified the Board of his decision to retire as a director of the Company effective January 1, 2025
On January 2, 2025, Lauren Sabella notified us of her intention to retire from MannKind Corporation (the “Company”), effective July 18, 2025
announced the departure of Roger A. Krone from the Board
On January 6, 2025, Skip Potter, Executive Vice President, Chief Digital Information Officer of Columbia Sportswear Company (the “Company”), departed the Company.
Effective December 31, 2024, Edward Schafer has stepped down as a member of the Board of Directors of the Company.
Dr. Robert Spiegel, Dr. Christopher Henney, Dr. Brian Schwartz, Dr. Kenneth Ferguson and Ms. Karin Walker (together, the "Resigning Directors") resigned effective as of the signing of the Purchase Agreement.
Dr. Robert Spiegel, Dr. Christopher Henney, Dr. Brian Schwartz, Dr. Kenneth Ferguson and Ms. Karin Walker (together, the "Resigning Directors") resigned effective as of the signing of the Purchase Agreement.
Dr. Robert Spiegel, Dr. Christopher Henney, Dr. Brian Schwartz, Dr. Kenneth Ferguson and Ms. Karin Walker (together, the "Resigning Directors") resigned effective as of the signing of the Purchase Agreement.
Mr. Spiro Rombotis resigned as Chief Executive Officer of the Company
Dr. Robert Spiegel, Dr. Christopher Henney, Dr. Brian Schwartz, Dr. Kenneth Ferguson and Ms. Karin Walker (together, the "Resigning Directors") resigned effective as of the signing of the Purchase Agreement.
Dr. Robert Spiegel, Dr. Christopher Henney, Dr. Brian Schwartz, Dr. Kenneth Ferguson and Ms. Karin Walker (together, the "Resigning Directors") resigned effective as of the signing of the Purchase Agreement.
Ms. Andrea DeMarco, President, Regent Seven Seas Cruises, would step down from her role in connection with the appointment of Mr. Jason Montague as Chief Luxury Officer, effective February 17, 2025.
On December 31, 2024, the Company determined that Ms. Andrea DeMarco, President, Regent Seven Seas Cruises, would step down from her role in connection with the appointment of Mr. Jason Montague as Chief Luxury Officer, effective February 17, 2025.
Robert R. Dillard separated from his position as the Chief Financial Officer of Sonoco Products Company
On January 6, 2025, Ulta Beauty, Inc. (the “Company”) announced that David C. Kimbell, the Company’s Chief Executive Officer, will retire from his position and from the Company’s Board of Directors
On January 6, 2025, Ulta Beauty, Inc. (the “Company”) announced that David C. Kimbell, the Company’s Chief Executive Officer, will retire from his position and from the Company’s Board of Directors
On January 2, 2025, Brian Wolfe, the Vice President, General Counsel and Secretary of Innovative Industrial Properties, Inc. (the “Company”), notified the Company of his intention to resign as an employee and officer of the Company effective January 9, 2025.
the Company and Daniel J. Booth, the Company’s Chief Operating Officer, mutually agreed that Mr. Booth’s employment with the Company would terminate effective January 2, 2025.
On December 31, 2024, Ying Luo, Ph. D. resigned as Chairman and a member of the board of directors (the “Board”) of Gyre Therapeutics, Inc. (the “Company”), as chair and a member of the Nominating and Corporate Governance Committee of the Board (the “Nominating Committee”) and as Chairman and a member of the board of directors of Gyre Pharmaceuticals Co., Ltd. (the “Gyre Pharmaceuticals Board”), the Company’s majority indirectly owned subsidiary (“Gyre Pharmaceuticals”), effective immediately, due to his need to focus on other responsibilities at GNI Group Ltd.
On December 30, 2024, Patrick F. Goepel, a director of Clearfield, Inc. (the “Company”), notified the Company of his decision not to stand for re-election to the Board of Directors (the “Board”) at the 2025 annual meeting of shareholders.
On January 6, 2025, D. Clay Bretches, Executive Vice President of Operations, notified APA Corporation (the “Company”) of his intention to retire from the Company, effective July 1, 2025.
J. Scott Wolchko retired from his positions as President, Chief Executive Officer (“CEO”), Chief Financial Officer, Treasurer, principal executive officer, principal financial officer and principal accounting officer of the Company, effective as of December 31, 2024
On January 1, 2025 (the “Dale Separation Date”), Stephen Dale, M.D. tendered his resignation from his position as the Chief Medical Officer of Kura Oncology, Inc. (the “Company”), effective as of January 2, 2025, in order to focus on recovery from personal health challenges.
On January 2, 2025, the Board of Directors (the “Board”) of Science Applications International Corporation (the “Company”) accepted the resignation of Dana S. Deasy, a member of the Board, including all committees thereof, effective as of January 2, 2025, in connection with a change in Hon. Deasy’s employment status.
On December 28, 2024, Colin Lim resigned from his position as a member of the board of directors (the “Board”) of Aerkomm Inc. (the “Company”), effective as of that date.
On December 30, 2024, Raymond Choy resigned from his position as a member of Board of the Company, effective as of that date.
On January 3, 2025, Kanat Mynzhanov provided notice of his decision to resign from the Board of Directors (the “Board”) of Borealis Foods Inc. to focus on his ongoing responsibilities as CEO of Tavia Acquisition Corp. Mr. Mynzhanov’s resignation is effective as of February 1, 2025, and did not result from any disagreement with the Company concerning any matter relating to the Company’s operations, polices, or practices.
On January 3, 2025, Gordon M. Burns notified Compass Diversified Holdings (NYSE: CODI) and the Board of Directors (the “Board”) of Compass Group Diversified Holdings LLC (the “Company” and, together with Compass Diversified Holdings, “CODI”) that he would not be standing for re-election as a director of the Company at CODI’s 2025 annual meeting of shareholders (the “2025 Annual Meeting”)
Jerome T. Walker notified the Board that he would not stand for re-election as a director of the Company at the 2025 Annual Meeting of Stockholders.
Cynthia Boiter notified the Board of her resignation as a member of the Board, effective May 1, 2025, for personal reasons.
On December 30, 2024, Jon Olsen resigned from his position as a member of the board of directors (the “Board”) of Firefly Neuroscience, Inc. (the “Company”), effective immediately.
In addition, on January 6, 2025, the Board removed Mr. Olsen from his position as the Company’s Chief Executive Officer without cause and appointed Greg Lipschitz as the Company’s Interim Chief Executive Officer.
On October 24, 2024, Craig Stephens, Board of Directors, resigned from the Board of Directors.
On November 22, 2024, Richard Schaeffer, Chairman of the Board of Directors, resigned from the Board of Directors.
On November 22, 2024, Najwa Aaraj, Board of Directors, resigned from the Board of Directors.
On November 22, 2024, Toney Jennings, Chief Executive Officer, resigned as the Chief Executive Officer.
On November 25, 2024, William Regan, Chief Financial Officer, resigned as the Chief Financial Officer.
On January 3, 2025, Robert Adams, Board of Directors, resigned from the Board of Directors.
Jeff Huddleston resigned from his position as Interim Chief Financial Officer of the Company, effective January 6, 2025.
On December 30, 2024, Lorne Weil resigned from the Board of Directors (the “Board”) of Tecnoglass Inc. (the “Company”).
On January 6, 2025, Generation Bio Co. (the “Company”) and Matthew Norkunas, MD, MBA agreed that they will enter into a separation agreement (the “Norkunas Separation Agreement”) for Dr. Norkunas’s departure as the Company’s Chief Financial Officer, effective as of January 10, 2025 (the “Effective Date”).
On January 6, 2025, the Company and Matthew Stanton, Ph.D. agreed that they will enter into a separation agreement (the “Stanton Separation Agreement”) for Dr. Stanton’s departure as the Company’s Chief Scientific Officer, effective as of the Effective Date.
effective January 3, 2025, Salvatore Rinaldi resigned as Chief Operating Officer of the Company and its subsidiary, Needham Bank (the “Bank”).
On January 6, 2025, The AZEK Company Inc. (the “Company”) announced that Mr. Peter Clifford is resigning from his positions as Senior Vice President, Chief Operations Officer and Chief Financial Officer of the Company, effective January 24, 2025
Effective December 31, 2024, each of Wallace D. Ruiz, Deborah Leff and Steve Pemberton (collectively, the “Resigning Directors”) resigned as members of the Board.
Effective December 31, 2024, each of Wallace D. Ruiz, Deborah Leff and Steve Pemberton (collectively, the “Resigning Directors”) resigned as members of the Board.
Effective December 31, 2024, each of Wallace D. Ruiz, Deborah Leff and Steve Pemberton (collectively, the “Resigning Directors”) resigned as members of the Board.
On January 4, 2025, the Company announced with deep sadness that Mr. Yoran had passed away on January 3, 2025.
Recent executive movements from 8-K Item 5.02 filings, source-linked. Cards are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.